Clinical Trial Update: A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 trial of frozen-and-thawed fecal microbiota transplantation for recurrent Clostridium difficile infection was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: McMaster University | Conditions: Clostridium Difficile | Phase 2 | Status: TERMINATED | Results posted: 2021-10-26